In Canada, the Food and Drug Act allows the distribution of drug samples to physicians, dentists, and pharmacists. 1 Most provincial regulatory authorities do not prohibit the distribution of such samples in health care settings. 2 However, drug samples are perceived differently by different health care stakeholders. 2 In particular, the use of drug samples may bypass the optimal druguse process in hospitals and retail pharmacies. [3] [4] [5] The objective of this cross-sectional observational study was to compare the number of drug samples available in outpatient clinics in a mother-child university hospital centre in the province of Quebec in 2007, 2009, and 2012. In the study hospital, drug samples were not allowed in patient wards but were tolerated in outpatient clinics. Drug samples were monitored every 6 months by pharmacy staff, who made unannounced visits to the clinics. In addition to biannual monitoring, extensive audits were conducted periodically over 1-to 2-week periods. During the first extensive audit, in 2007, the number of units (e.g. tablets, vials) of drug samples in all outpatient clinics was counted. The audit was repeated in November 2009 and July 2012. For each audit period, the total numbers of both units and doses of drug samples were calculated, and the average number of doses was estimated for liquids (0.5 mL/dose) and topical agents (0.5 g/dose). The number of doses of drug samples per patient visit was also calculated, to indicate potential exposure of patients to samples.
In total, 31 locations (i.e., health care units) were identified in 21 outpatient clinics. A total of 14 221 units of drug samples were counted in 2007, 8080 units in 2009, and 6989 units in 2012 (see details in Table 1 In 2012, only 19% of doses documented during the audit were listed on the official hospital drug formulary; in addition, 4% of the doses were expired. Despite implementation of a Web-based intranet form to declare drug samples received from industry sales representatives, most doses of drug samples had not been declared to the pharmacy by hospital staff.
The availability of drug samples in outpatient clinics at the study hospital has remained stable for the past 5 years. It may seem feasible to prohibit the distribution of samples locally in outpatient clinics, but in fact, it is difficult to do so when such distribution is not prohibited by the pertinent regulatory authorities. For instance, physicians and medical residents often work in multiple hospitals, and their regulations regarding drug samples may vary. We believe that drug samples do not contribute to better patient care and should only be dispensed by retail pharmacies through a structured approach, with documentation of doses dispensed in the patient's record.
